Biology-Driven Drug and Target Discovery Platform
Fountain’s platform leverages the biology of aging to identify the mechanisms that connect aging with disease
Cellular aging drives disease development and progression
Fountain’s technology analyzes the biologic and phenotypic characteristics of donor cells to develop models that score age and disease
much like how one can use a face to estimate age
or a pathologist uses tissue histology to diagnose disease
Fountain’s platform enables the application of complex disease phenotypes in high-throughput and high-content screens and identifies
Disease Modifying Drugs and Targets
Coupling of in vitro and in vivo screening rapidly identifies leads that demonstrate disease-modifying activity